Media Summary: Our new strategic plan will serve as a foundational document for Speakers: Amanda Allard, Ph.D, Director of Pharmaceutical Reviews, Health technology assessment (HTA) plays a key role in decisions about the use of medical devices in Canada. This

Cadth Information Session December 2022 - Detailed Analysis & Overview

Our new strategic plan will serve as a foundational document for Speakers: Amanda Allard, Ph.D, Director of Pharmaceutical Reviews, Health technology assessment (HTA) plays a key role in decisions about the use of medical devices in Canada. This What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at ...

Photo Gallery

CADTH Information Session - December 2022
CADTH Drug Portfolio Information Session
2022 CADTH Information Session: Portfolio and Program Updates
CADTH Drug Reimbursement Reviews
2022 CADTH Information Session: CADTH’s 2022–2025 Strategic Plan
CADTH and INESSS and the future of HTA Processes
Join CADTH and find your something more.
CADTH Drug Portfolio Information Sessions
CADTH Medical Device Portfolio Information Session
CADTH
INFORMATION SESSION — Introducing CADTH’s New Post-Market Drug Evaluation Program
Market access and reimbursement in Canada – changes at CADTH
View Detailed Profile
CADTH Information Session - December 2022

CADTH Information Session - December 2022

The

CADTH Drug Portfolio Information Session

CADTH Drug Portfolio Information Session

This annual

2022 CADTH Information Session: Portfolio and Program Updates

2022 CADTH Information Session: Portfolio and Program Updates

Our new strategic plan will serve as a foundational document for

CADTH Drug Reimbursement Reviews

CADTH Drug Reimbursement Reviews

CADTH

2022 CADTH Information Session: CADTH’s 2022–2025 Strategic Plan

2022 CADTH Information Session: CADTH’s 2022–2025 Strategic Plan

Our new strategic plan will serve as a foundational document for

CADTH and INESSS and the future of HTA Processes

CADTH and INESSS and the future of HTA Processes

Speakers: Amanda Allard, Ph.D, Director of Pharmaceutical Reviews,

Join CADTH and find your something more.

Join CADTH and find your something more.

Look no further. At

CADTH Drug Portfolio Information Sessions

CADTH Drug Portfolio Information Sessions

This annual

CADTH Medical Device Portfolio Information Session

CADTH Medical Device Portfolio Information Session

Health technology assessment (HTA) plays a key role in decisions about the use of medical devices in Canada. This

CADTH

CADTH

Guest presentation by Jill Sutherland on

INFORMATION SESSION — Introducing CADTH’s New Post-Market Drug Evaluation Program

INFORMATION SESSION — Introducing CADTH’s New Post-Market Drug Evaluation Program

The new

Market access and reimbursement in Canada – changes at CADTH

Market access and reimbursement in Canada – changes at CADTH

What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at ...

CADTH Information Session: PMDE Program Request for Standing Offers

CADTH Information Session: PMDE Program Request for Standing Offers

In